Shuang Hu
Guangdong Pharmaceutical University(CN)Southern Medical University(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Hippo pathway signaling and YAP/TAZ, Gut microbiota and health, Hepatocellular Carcinoma Treatment and Prognosis, Epigenetics and DNA Methylation
Most-Cited Works
- → Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer(2022)11 cited
- → Efficacy comparison of fruquintinib, regorafenib monotherapy or plus programmed death-1 inhibitors for microsatellite stable metastatic colorectal cancer(2024)5 cited
- → Pregnane X receptor activation promotes hematopoiesis during liver regeneration by inducing proliferation of hematopoietic stem and progenitor cells in mice(2024)3 cited
- → Pregnane X receptor alleviates sepsis-induced liver injury through activation of yes-associated protein in mice(2025)1 cited
- → Constitutive androstane receptor activation modulates YAP expression and activity through ubiquitination and sumoylation(2025)1 cited
- → Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats(2024)1 cited
- → Gut microbiota affects the role of mPXR agonist PCN in alleviating sepsis-induced liver injury by regulating YAP activation(2025)